Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Pre-infusion plasma proteomics identifies an endothelial-immune priming signature predictive of severe cytokine release syndrome and neurotoxicity following CAR T-cell therapy in relapsed/refractory lymphoma.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the "Ceiling Efficacy Effect" of Modern Antifungals?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 30, 2026
Ruxolitinib Meets a Forgotten Malady.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 19, 2025
Microbial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?
Journal: Current opinion in infectious diseases
Published: September 08, 2025
Trends in antifungal use among hospitalized patients in the USA, 2018-23.
Journal: The Journal of antimicrobial chemotherapy
Published: May 13, 2025
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients.
Journal: Transplantation and cellular therapy
Published: January 27, 2025
Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?
Journal: Expert review of molecular diagnostics
Published: December 03, 2024
Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia.
Journal: Cancers
Published: August 28, 2024
Predicting COVID 19-Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study.
Journal: Open forum infectious diseases
Published: March 11, 2024
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia.
Journal: The Journal of antimicrobial chemotherapy
Published: February 28, 2024
Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections.
Journal: Journal of fungi (Basel, Switzerland)
Published: February 24, 2024
Last Updated: 09/26/2026